Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CenraTPE:3716 -0.46%15 Days Payable is 52.41 as of Dec. 2025, which is 9% below its 10-year median of 57.38. GuruFocus rates TPE:3716 with a GF Score™ of 15/100. The stock has 4 warning signs investors should review. Among 116 Medical Distribution companies, Cenra ranks worse than 73.28% on this metric.
Cenra's average Accounts Payable for the
three
months ended in Dec. 2025 was NT$759 Mil. Cenra's Cost of Goods Sold for the
three
months ended in Dec. 2025 was NT$1,321 Mil.
Hence, Cenra's Days Payable for the
three
months ended in Dec. 2025 was 52.41.
The historical rank and industry rank for Cenra's Days Payable or its related term are showing as below:
TPE:3716'
s Days Payable Range Over the Past 10 Years
Min: 54.37 Med: 57.38 Max: 58.6
Current: 54.45
During the past 5 years, Cenra's highest Days Payable was 58.60. The lowest was 54.37. And the median was 57.38.
TPE:3716's Days Payable is ranked worse than 73.28% of 116
companies
in the Medical Distribution industry
Industry Median: 78.565
vs TPE:3716: 54.45
Cenra's Days Payable
declined
from Dec. 2024 (57.37) to Dec. 2025 (52.41).
It may suggest that Cenraaccelerated paying its suppliers.
The historical data trend for Cenra's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:3716 vs MCK, COR, CAH: Days Payable Comparison
For the Medical Distribution subindustry, Cenra's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cenra Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cenra's Days Payable distribution charts can be found below:
* The bar in red indicates where Cenra's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Cenra's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cenra (TPE:3716) has a Days Payable of 52.41 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cenra and its competitors. This is near median its historical median of 57.38. Over the past decade, Cenra's Days Payable has ranged from 54.37 to 58.60. According to the industry distribution chart, Cenra ranks #85 out of 116 companies in the Medical Distribution industry, placing it in the top 73.3%.
Is Cenra's Days Payable too high?
Cenra's current Days Payable of 52.41 is near median its 10-year median of 57.38. Over the past 10 years, this metric has ranged from a low of 54.37 to a high of 58.60. The Medical Distribution industry median Days Payable is 78.57. Cenra's value of 52.41 is 33.3% below this industry median. Based on the distribution chart, Cenra ranks #85 out of 116 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Cenra has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Cenra's Days Payable compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Cenra ranks #85 out of 116 companies for Days Payable. This places Cenra in the lower half of its industry. The industry median Days Payable is 78.57. Cenra's value of 52.41 is 33.3% below this benchmark. Historically, Cenra's own Days Payable has ranged from 54.37 to 58.60 over the past decade. While the company's 10-year median is 57.38 vs. the industry median of 78.57, Cenra has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 78.57, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cenra's current Days Payable of 52.41 is 33.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cenra and its competitors. For the Medical Distribution industry, the median Days Payable is 78.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cenra's current Days Payable is 52.41, which is near median its own 10-year median of 57.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cenra stock overvalued right now?
Cenra (TPE:3716) has a current Days Payable of 52.41. The current Days Payable is 52.41, which is near median its 10-year median of 57.38 and 33.3% below the Medical Distribution industry median of 78.57. Cenra's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cenra (TPE:3716), the current Days Payable is 52.41 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:3716 has been successfully added to your 
